Community/Retail

According to TherapeuticsMD, Bijuva is the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms due to menopause in women with a uterus.

Despite a decline in the rate of opioid prescribing, the CDC reports that the number of opioid related deaths continues to rise. The pharmacology and pharmacokinetics of prescription and illicit fentanyl could help to shed light on why the opioid epidemic has taken the path that it has.

Costume contact lenses are gaining popularity, but there are concerns with these products.

Having a pharmacy that truly matters can make all the difference in the world to your patients, and to your bank account.

In the lexicon of management, the owner is the epitome of leadership. Yet surprisingly, according to the Harvard Business Review, little is known about this unique role.

Officials with the FDA have approved Jazz Pharmaceuticals' Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness (EDS) in pediatric patients aged 7 to 17 years with narcolepsy.

In this series, Jill Drury, PharmD, a clinical pharmacy specialist, provides patients with "Brown Bag" consultations. Patients bring to the pharmacy their current medications and over-the-counter products, giving the pharmacist an additional resource for pharmaceutical counsel. In this video, a patient with fair skin is planning a tropical vacation. She seeks advice about topical skin protection and potential adverse effects from the sun with her medications.

Several studies represent some of the important clinical trials in the treatment of Non-Hodgkin's Lymphoma.

Tildrakizumab-asmn (Ilumya), an injectable interleukin-23 (IL-23) inhibitor, was approved by the FDA in March for adults who are candidates for systemic therapy or phototherapy.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A antiviral has been FDA-approved, just in time for flu season.

Any woman who has tried being both a full-time mother and a full-time student can tell you that is not an easy task.

Amgen will make evolocumab (Repatha) available at a list price of $5850, a 60% reduction from its annual list price of $14,1000.

Drug manufacturers, patient advocates, and professional organizations are giving a big thumbs-up to the SUPPORT for Patients and Communities Act.

Officials with the FDA have approved baloxavir marboxil (Xofluza, Shionogi) for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours.

Panelists will discuss and collaboratively provide an overview of medical cannabis, identify the therapeutic role of cannabis, examine the regulation of medical cannabis and establish the role of health care providers in prescribing medical cannabis.

Breckenridge Pharmaceutical's Clobazam Tablets, CIV, generic for Onfi® Tablets (Lundbeck), has been granted FDA approval for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients aged 2 years and older.

Beginning in spring 2019, all Walgreens pharmacies that do not offer a safe medication disposal kiosk will stock a take home safe medication disposal kit in the pharmacy that will be available at no cost upon patient request.

Chickenpox parties coordinated through social media are becoming a dangerous trend due to the anti-vaccine movement.

According to the complaint filed with the consent decree, Keystone's products were not manufactured, processed, packed or held according to CGMP requirements.

The vaccine, produced by Seqirus, was first approved in the United States in August 2016 for adults 18 and older.

To target the infrastructure supporting the illegal online sales of drugs, a series of recent OCI cybercrime investigations focused on credit card processors involved in an arrangement known as “transaction laundering” or “factoring.”

New data from the investigational multiple sclerosis (MS) drug evobrutinib showed that the therapy reduced lesions and decreased annual relapse rates in patients with relapsing MS.

Anti-tumor necrosis factor (TNF) agents were the most commonly prescribed bDMARDs in this cohort.

The FDA will address new ways to increase the availability of naloxone, during a 2-day advisory committee meeting in December.

The FDA has approved dupilumab (Dupixent®, Regeneron and Sanofi) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an eosinophilic phenotype or with oral corticosteroid-dependent asthma.

Critical care is a rapidly expanding pharmacy specialty, and today's pharmacy student have more opportunities than ever to bceome successful critical care pharmacist.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

CDC officials note that it is safe to be around infants and young children, pregnant women, or people with weakened immune systems after you get the shingles vaccine.

Want to increase cash flow and profits? And create more wealth in the process? There are 3 powerful tools to accomplish that.